Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

FDA grants priority review to Dova's NDA for avatrombopag

Nov. 28, 2017

Pharming submits sBLA for Ruconest for prevention of HAE attacks

Nov. 27, 2017

FDA gives orphan drug status to TRM-201 for hemophilic arthropathy

Nov. 22, 2017

BMS-986141 prevents arterial thrombosis in monkeys

Nov. 22, 2017

Desidustat approved as INN for Zydus Cadila's ZYAN-1

Nov. 22, 2017

Genexine's recombinant human erythropoietin effective in patients on dialysis

Nov. 21, 2017

Sumitomo Dainippon Pharma discloses TLR7 antagonists

Nov. 20, 2017

Phase III HAVEN 3 study of emicizumab in hemophilia A meets endpoints

Nov. 20, 2017

FDA first to approve Hemlibra for hemophilia A

Nov. 17, 2017

Shire's Adynovi receives positive opinion in E.U.

Nov. 14, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...